Live Breaking News & Updates on Director Arie Belldegrun
Stay updated with breaking news from Director arie belldegrun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month […] ....
Piper Sandler initiated coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a report published on Friday, Marketbeat reports. The brokerage issued an overweight rating and a $11.00 target price on the stock. ALLO has been the subject of several other research reports. Royal Bank of Canada reissued an outperform rating and issued […] ....
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) have been assigned an average recommendation of “Buy” from the fifteen ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price […] ....